We use variants of the peptides GLP-1 and exendin-4 (Ex4) to explore the interplay between helical propensity near the agonist N terminus and the ability to bind to and activate the receptor
some platforms offer detailed progress notes and medication adjustments, while others provide minimal guidance between refills
Consequently, although obesity affects hundreds of millions of people globally, GLP-1 therapies currently reach only a small fraction of eligible patients, underscoring the substantial unmet need for more convenient, scalable, and accessible treatment options
While our generous sponsors make the Ask the MD program possible, their support does not influence MJFFs content or perspective.
These injections work by regulating appetite, helping patients feel fuller longer, and reducing cravings
One is multi-use safety, whereas the other is pure single-use